A new editorial paper was published in Oncoscience (Volume 10) on June 28, 2023, entitled, "Adenoid cystic carcinoma of the head and neck – treatment strategies of a highly malignant tumor with ...

Adenoid cystic carcinoma (ACC) of the breast is a rare and distinctive form of breast cancer, accounting for less than 0.1% of all breast malignancies. Despite its triple‐negative immunophenotype, ...

Learn about Adenoid Cystic Carcinoma- key symptoms, diagnosis methods, and treatment options for managing this rare cancer ...

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes Eligible patients had R/M ACC with progression within 6 months before enrollment. Treatment ...

Researchers from the MD Anderson Cancer Center presented data from a study that assessed the tumor microenvironment (TME) of adenoid cystic carcinoma (ACC) with the aim of identifying novel ...

Rgenta Therapeutics Inc. has received IND clearance by the FDA for RGT-61159, which is being developed for adenoid cystic carcinoma, colorectal cancer and other solid tumors, as well as acute myeloid ...

A new paper published by researchers at Fox Chase Cancer Center highlights the case of a patient who was diagnosed with adenoid cystic carcinoma (ACC) after a molecular panel identified the presence ...

Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology Group Study E2399 Of ...

“Proton therapy [...] seems to have decisive advantages with regard to the long-term survival of [adenoid cystic carcinoma] [...]” In general, tumors originating from the minor salivary glands often ...